Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

OBJ

OBJ
PUBLIC STATUS
1-10 EMPLOYEES
OBJ STOCK SYMBOL
1 INVESTMENTS
$0.01 SHARE PRICE (As of Thursday Closing)
Description

OBJ Ltd is engaged in the research and development for Dermaportation and ETP transdermal drug delivery technologies. Geographically, it derives a majority of revenue from Singapore and also has a presence in Japan. It serves Pharmaceutical; Cosmetics and Skincare and Consumer Healthcare industries.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Delivery
Stock Exchange
ASX
Primary Office
  • Perth
  • Australia
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore OBJ’s full profile, request a free trial.

OBJ Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$18.7M $0.01 1.18M 1.81B

OBJ Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 18,162 15,870 33,590 61,535
Revenue 893
EBITDA (1,197) (1,303) (4,164)
Net Income (1,223) (1,316) (4,173)
Total Assets 2,197 3,531 4,769
Total Debt 176 175 172
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OBJ Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 0000000 07-Nov-2019 000000000000000000 0000 Food Products
To view this company’s complete investment and acquisition history, request access »

OBJ Executive Team (1)

Name Title Board
Seat
Contact
Info
Jeff Edwards Managing Director